imaprelimab   Click here for help

GtoPdb Ligand ID: 9805

Synonyms: PRX-003 | PRX003
Immunopharmacology Ligand
Compound class: Antibody
Comment: Imaprelimab (PRX-003) is an anti-MCAM mAb developed as a novel therapy for psoriasis. In patients with autoimmune diseases, a subset of MCAM+ve T cells (which have an effector memory T-helper 17 phenotype) produce high levels of pro-inflammatory IL-17 [1,3]. Pharmacological disruption of MCAM function is thought to be a valid mechanism for the treatment of autoimmune inflammation. Peptide sequence alignments identify imaprelimab as one of the preferred antibodies claimed in patent WO2014039975 [2] (SEQ IDs 119 and 123 match the sequences submitted to the WHO for INN imaprelimab). These peptide sequences map to the construct identified as h2120VH5/L3.
Click here for help
Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
10753 imaprelimab
Synonyms Click here for help
PRX-003 | PRX003
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 808
Other databases
GtoPdb PubChem SID 354702277
Search PubMed clinical trials imaprelimab
Search PubMed titles imaprelimab
Search PubMed titles/abstracts imaprelimab